Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamics of Formoterol Fumarate Inhalation Solution vs Foradil Aerolizer in COPD
NCT01113593Phase 2Completed
- Sponsor
- Dey
- Start
- May 2010
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of formoterol in chronic obstructive pulmonary disease (COPD), sponsored by Dey. Started May 2010; status: completed.
02
Drugs
formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01113593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01113593.